News Biosynex

Equities

ALBIO

FR0011005933

Market Closed - Euronext Paris Other stock markets 09:05:25 28/06/2024 pm IST			5-day change	1st Jan Change
2.83 ^EUR	-10.16%		-15.14%	-66.11%

28/05	Biosynex: obtains CE markings under the new IVDR regulations	CF
13/05	Biosynex: Oren Bitton appointed Chief Operating Officer	CF

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Biosynex: obtains CE markings under the new IVDR regulations	28/05	CF
Biosynex: Oren Bitton appointed Chief Operating Officer	13/05	CF
Biosynex SA Reports Earnings Results for the Full Year Ended December 31, 2023	01/05	CI
Biosynex: agreement for ProciseDx in North America	29/04	CF
Biosynex: merger with Theradiag completed	18/12	CF
Biosynex SA Reports Earnings Results for the Half Year Ended June 30, 2023	30/23/30	CI
Biosynex: acquisition of Qualigen in the United States	21/23/21	CF
Biosynex Unit to Acquire US-based Biotech Qualigen	21/23/21	MT
Biosynex SA acquired 57.33% interest in ProciseDx Inc. from Nestlé HealthCare Nutrition, Inc., other shareholders, employees, former employees and investors.	13/23/13	CI
Biosynex SA signed an agreement to acquire 57.33% interest in ProciseDx Inc. from NestlÃ© HealthCare Nutrition, Inc., other shareholders, employees, former employees and investors.	12/23/12	CI
Biosynex: acquires Innoxa's eye care business	08/23/08	CF
Biosynex SA acquired Eye Care activity from LABORATOIRES INNOXA.	08/23/08	CI
Biosynex Completes Acquisition of Chembio Diagnostics, Inc.	28/23/28	AQ
Biosynex SA completed the acquisition of Chembio Diagnostics, Inc. from Perceptive Advisors LLC and others.	27/23/27	CI
Global markets live: EssilorLuxottica, AT&T, Tesla, Credit Suisse, Sony...	21/23/21
Biosynex: share price falls as results deteriorate	21/23/21	CF
Biosynex SA Reports Earnings Results for the Full Year Ended December 31, 2022	20/23/20	CI
Chembio Diagnostics Tender Offer Expiration Extended by Biosynex	13/23/13	MT
Biosynex Extends Tender Offer for the shares of Chembio Diagnostics, Inc.	13/23/13	AQ
Biosynex: takeover bid extended for Chembio Diagnostics	29/23/29	CF

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Biosynex

Equities

ALBIO

FR0011005933

Summary

Filters